Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended 30 April 2019

NEXT STORY
Kiniksa Presents Preclinical Data on the GM-CSF Signaling Pathway in Temporal Arteries of GCA Patients at the Annual European Congress of Rheumatology 
PREV STORY
Precision BioSciences Appoints Dario Scimeca as General Counsel
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ZIOPHARM Announces Three Presentations at the 2017 Annual Meeting of the Society for Neuro-Oncology

BOSTON, Oct. 12, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Hemispherx Biopharma Announces Corporate Progress and Financial Results for the Six Months Ended June 30, 2017

The Company has Generated Revenues and Advanced in R&D for Intranasal Ampligen and in ...

author_avatar
NASDAQ Market News

Galena Biopharma Presents GALE-401 Combined Safety Data at the European Hematology Association 21st Congress

SAN RAMON, Calif., June 13, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...

author_avatar
NASDAQ Market News